Showing results (431-440 of 546) with videos related to

Sort By:
Pageof 55
International Journal of Cancer|December 21, 2024
Head-to-head comparison of palbociclib and ribociclib in first-line treatment of HR-positive/HER2-negative metastatic breast cancer with real-world data from the OPAL registryMarc Thill, Mark-Oliver Zahn, Anja Welt, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Treatment of Patients with Early Breast Cancer: Evidence, Controversies, Consensus: German Expert Opinions on the 17th International St. Gallen Consensus ConferenceMichael Untch, Peter A Fasching, Sara Y Brucker, et al.
Nature Neuroscience|May 17, 2005
LINGO-1 negatively regulates myelination by oligodendrocytesSha Mi, Robert H Miller, Xinhua Lee, et al.
Cancers|March 6, 2021
Predicting Prognosis of Breast Cancer Patients with Brain Metastases in the BMBC Registry-Comparison of Three Different GPA Prognostic ScoresKerstin Riecke, Volkmar Müller, Rudolf Weide, et al.
ESMO Open|November 10, 2022
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)M Schmidt, K Lübbe, T Decker, et al.
International Journal of Cancer|March 18, 2026
Prediction of dose reductions and impact of reduced starting doses of CDK4/6i on effectiveness in HR-positive/HER2-negative metastatic breast cancer: Real-world data from the OPAL registryPatrick Marschner, Kai Ringwald, Marc Thill, et al.
Breast Care (Basel, Switzerland)|August 12, 2022
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus ConferenceCornelia Kolberg-Liedtke, Diana Lüftner, Sara Y Brucker, et al.
ESMO Open|June 11, 2026
First-line ET plus palbociclib versus standard mono-chemotherapy in high-risk HR-positive/HER2-negative metastatic breast cancer and indication for chemotherapy: primary results from the randomized phase IV PADMA studyM Schmidt, M Thill, J Rey, et al.
Geburtshilfe Und Frauenheilkunde|April 24, 2020
Update Breast Cancer 2020 Part 2 - Advanced Breast Cancer: New Treatments and Implementation of Therapies with Companion DiagnosticsDiana Lüftner, Andreas Schneeweiss, Andreas D Hartkopf, et al.
Geburtshilfe Und Frauenheilkunde|June 25, 2021
Update Breast Cancer 2021 Part 3 - Current Developments in the Treatment of Early Breast Cancer: Review and Assessment of Specialised Treatment Scenarios by an International Expert PanelTanja N Fehm, Elmar Stickeler, Peter A Fasching, et al.
Pageof 55